Russia's MD Medical says no new share sale if price below $12

MOSCOW (Reuters) - Russia's MD Medical Group will not proceed with a secondary public offering if the shares cannot fetch at least $12, Mark Kurtser, its main shareholder and chief executive, told Reuters.